TRPV1 and neoplasm: These IS-Micelles showed distinct thermotherapeutic efficacies against primary, metastatic and recurrent TNBCs, a variety of TRPV1-positive malignant human tumors including HepG2, MDA-MB-231 and PANC1 tumors, as well as small, large and orthotopic HCT-116 tumor models.